Michael Gelband’s Prestige Consumer Healthcare PBH Stock Holding History

Michael Gelband’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19,574	Closed	-$1.21M	–	1963
2025 Q4	$1.21M	Buy	+19,574	New	+$1.2M	0.01%	923
2023 Q4	–	Sell	-27,644	Closed	-$1.58M	–	1909
2023 Q3	$1.58M	Sell	27,644 -48,985	-64%	-$2.96M	0.02%	762
2023 Q2	$4.55M	Buy	76,629 +27,838	+57%	+$1.67M	0.04%	482
2023 Q1	$3.06M	Buy	+48,791	New	+$3.05M	0.03%	712
2022 Q4	–	Sell	-32,420	Closed	-$1.61M	–	2008
2022 Q3	$1.61M	Buy	32,420 +21,951	+210%	+$1.22M	0.02%	900
2022 Q2	$616K	Sell	10,469 -36,998	-78%	-$2.04M	0.01%	1277
2022 Q1	$2.51M	Buy	47,467 +39,792	+518%	+$2.3M	0.03%	675
2021 Q4	$465K	Buy	+7,675	New	+$456K	﹤0.01%	1462
2021 Q2	–	Sell	-19,369	Closed	-$854K	–	2687
2021 Q1	$854K	Buy	+19,369	New	+$814K	0.01%	1011

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Michael Gelband's PBH Position: Q1 2026 in Review

Michael Gelband sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 19,574 shares — an estimated $1.21M sold.

Michael Gelband first reported a position in PBH in Q1 2021 and held it in 9 quarters. The position peaked at $4.55M in Q2 2023. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

Michael Gelband reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
Michael Gelband sold 19,574 Prestige Consumer Healthcare shares in Q1 2026, an estimated $1.21M.
Michael Gelband first reported a position in Prestige Consumer Healthcare in Q1 2021 and held it in 9 quarters.
Michael Gelband's Prestige Consumer Healthcare position peaked at $4.55M in Q2 2023.
355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.